Revenue by source
Coopervision Segment$2.74BCoopersurgical Segment$1.35BCoopersurgical$0.00
| Segment | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Coopervision Segment | $1.19B | $1.27B | $1.39B | $1.49B | $1.58B | - | $1.88B | $1.97B | $1.84B | $2.15B | $2.24B | $2.42B | $2.61B | $2.74B |
| Coopersurgical Segment | $255.89M | $319.41M | $325.13M | $309.30M | $389.60M | - | $650.80M | $680.50M | $587.90M | $770.50M | $1.07B | $1.17B | $1.29B | $1.35B |
| Coopersurgical | - | - | - | - | - | $464.90M | - | - | - | - | - | - | - | - |
Revenue by country
UNITED STATES$2.73BEurope$2.38BRest Of World, Excluding United States And Europe$785.20M
| Segment | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $879.35M | $972.60M | $1.00B | $1.06B | $1.14B | $1.19B | $1.44B | - | $1.50B | $1.83B | $2.15B | $2.38B | $2.57B | $2.73B |
| Europe | $727.01M | $805.48M | $928.43M | $1.14B | $1.15B | $1.19B | $1.25B | $1.16B | $1.12B | $1.77B | $1.88B | $2.06B | $2.22B | $2.38B |
| Rest Of World, Excluding United States And Europe | - | - | - | - | - | - | - | - | $537.50M | $625.40M | $682.70M | - | $773.60M | $785.20M |